We have developed a new and simple method of p-aminohippuric acid determination by use of dimethylaminocinnamaldehyde (DACA).It differs from previous methods using DACAin that the reaction is carried out in ethanol rather than in dilute acid. This results in deeper and more stable color development. We have used this method successfully to determine effective renal plasma flow in a clinical study of this variable in pregnant women.
The clearance ofp-aminohippuric acid (PAH) continues to be used to measure "effective" renal plasma flow in research settings.
Current methodology for this analyte involves reacting the specimen with a chromogenic aldehyde, dimethylaminocinnamaldehyde (DACA), in dilute acid (1). We have found that by using DACA in ethanol instead, the color is formed more directly, and is deeper and more stable.
MaterIals and Methods
Centrifuge, for 4 mm at 100 x g, PAll standard solutions and samples of plasma or urine with equal volumes (0.25 mL is sufficient) of a 150 g/L trichloroacetic acid solution in water. Combine 0.25 mL of the clear supernate with 1.75 mL of DACA (Aldrich Chemical Co., Milwaukee, WI; cat. no. D14040-6) solution, 10 g/L, in 95% ethanol, and shake vigorously for 15 s. Measure the absorbance at 550 nm after 10 mm, using a 10 mm (pathlength) glass cuvette. We used a Model 24 spectrophotometer (Beckman Instruments, Brea, CA) and assayed all samples in duplicate.
To test the reliability of measuring PAH in biological fluids, we added 0.2 mL of a 1.0 g/L stock solution of aqueous PAll to 9.80 mL of plasma obtained from heparinized whole blood (25 USP units of heparin per milliliter of blood); we also added 4.0 mL of the same stock solution to 100 mL of 20-fold diluted urine. We tested for possible interference from p-amino compounds, including sullanilamide, procainamide, and p-aminobenzoic acid at approximate therapeutic concentrations.
In collaboration with the Departments of Medicine and Obstetrics,we used this method of PAll determination to evaluate effective renal plasma flow in pregnant women at 28-34 weeks of gestation. We used the clearance tests described by Smith (2), with the following modifications: (a) Urine was collected by spontaneous voiding. 
Results and DiscussIon
At In the renal-clearance studies,samples collected from 14 patients in 15 trials during six months yielded PM! clearances of 829 ± 47.4 mL effective renal plasma flow per minute (mean ± SEM, range 512-1145), which is close to published values (4). The CV for individual patients was 7.07 ± 1.31% (range 1.40-10.9%), which is similar to the previously reported value of 6.3% for normal, nonpregnant volunteers (5).
